Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Die Urologie
Erschienen in: Der Urologe 6/2006

01.06.2006 | CME Weiterbildung · Zertifizierte Fortbildung

Benignes Prostatasyndrom (BPS)

Ablative Verfahren

verfasst von: PD Dr. O. Reich, M. Seitz, C. Gratzke, B. Schlenker, A. Bachmann, C. Stief

Erschienen in: Die Urologie | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die instrumentellen Verfahren zur Behandlung des benignen Prostatasyndroms (BPS) werden heute im Rahmen eines abgestuften Therapieschemas eingesetzt, oft nach vorangegangener medikamentöser Therapie. Neben der seit Jahrzehnten bewährten Standardmethode, der transurethralen Resektion der Prostata (TURP) und deren z. T. essenziellen Modifikationen („Vaporesektion“; bipolare Resektion), gelangen zunehmend alternative operative Verfahren, wie transurethrale Mikrowellentherapie (TUMT), transurethrale Nadelablation der Prostata (TUNA) oder Laservaporisation bzw. -resektion, in den Fokus des Interesses. Unter Zuhilfenahme der aktuellen Datenlage, vorzugsweise aus randomisierten kontrollierten Studien („randomized controlled trials“, RCT), wird zu den einzelnen Verfahren kritisch Stellung bezogen. Darüber hinaus wird der Stellenwert der offenen Prostataadenomenukleation dargelegt.
Literatur
1.
Adam C, Hofstetter A, Deubner J et al. (2004) Retropubic transvesical prostatectomy for significant prostatic enlargement must remain a standard part of urology training. Scand J Urol Nephrol 38: 472–476CrossRefPubMed
2.
Alschibaja M, May F, Treiber U et al. (2005) Transurethral resection for benign prostatic hyperplasia. Current developments. Urologe A 44: 499–504CrossRefPubMed
3.
AUA (2003) Guideline on management of benign prostatic hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530–547CrossRefPubMed
4.
Bachmann A, Reich O, Wyler S et al. (2004) The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures. Urologe A 43: 1262–1270CrossRefPubMed
5.
Bachmann A, Ruszat R, Wyler S et al. (2005) Photoselective vaporization of the prostate: the Basel experience after 108 procedures. Eur Urol 47: 798–804CrossRefPubMed
6.
Bachmann A, Schurch L, Ruszat R et al. (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48: 965–972CrossRefPubMed
7.
Berges R, Dreikorn K, Hofner K et al. (2003) Guidelines of German urologists on therapy of benign prostate syndrome. Urologe A 42: 722–738PubMed
8.
Bernie JE, Schmidt JD (2003) Simple perineal prostatectomy: lessons learned from a modern series. J Urol 170: 115–118CrossRefPubMed
9.
Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM (2004) A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 94: 83–88CrossRefPubMed
10.
Chapple CR, Issa MM, Woo H (1999) Transurethral needle ablation (TUNA). A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia. Eur Urol 35: 119–128CrossRefPubMed
11.
Chinpairoj S, Feldman MD, Saunders JC, Thaler ER (2001) A comparison of monopolar electrosurgery to a new multipolar electrosurgical system in a rat model. Laryngoscope 111: 213–217CrossRefPubMed
12.
Costello AJ, Agarwal DK, Crowe HR, Lynch WJ (1999) Evaluation of interstitial diode laser therapy for treatment of benign prostatic hyperplasia. Tech Urol 5: 202–206PubMed
13.
Daehlin L, Frugard J (2000) Transurethral microwave thermotherapy in the management of lower urinary tract symptoms from benign prostatic obstruction: follow-up after five years. Scand J Urol Nephrol 34: 304–308CrossRefPubMed
14.
De La Rosette JJ, Gravas S, Muschter R et al. (2003) Present practice and development of minimally invasive techniques, imaging and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol 44: 346–351CrossRefPubMed
15.
de Sio M, Autorino R, Quarto G et al. (2006) Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology 67: 69–72CrossRefPubMed
16.
Dunsmuir WD, McFarlane JP, Tan Aet al. (2003) Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis 6: 182–186CrossRefPubMed
17.
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49: 87–91CrossRefPubMed
18.
Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new „gold standard“. Urology 66: 108–113CrossRef
19.
Faul P, Farin G, Reich O, Steude U (1996) The ‚band electrode’: first experiences with a novel TURP procedure to improve hemostasis. Eur Urol 30: 403–408PubMed
20.
Freyer PJ (1912) One thousand cases of total enucleation of the prostate for radical cure of enlargement of that organ. BMJ 11: 868–870
21.
Fung BT, Li SK, Yu CF et al. (2005) Prospective randomized controlled trial comparing plasmakinetic vaporesection and conventional transurethral resection of the prostate. Asian J Surg 28: 24–28PubMed
22.
Gilling PJ, Mackey M, Cresswell M et al. (1999) Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 162: 1640–1644CrossRefPubMed
23.
Greenberger M, Steiner MS (1998) The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: interim analysis. World J Urol 16: 386–391CrossRefPubMed
24.
Gupta NP, Doddamani D, Aron M, Hemal AK (2002) Vapor resection: a good alternative to standard loop resection in the management of prostates >40 cc. J Endourol 16: 767–771CrossRefPubMed
25.
Gupta N, Sivaramakrishna, Kumar R et al. (2006) Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int 97: 85–89CrossRefPubMed
26.
Hai MA, Malek RS (2003) Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17: 93–96CrossRefPubMed
27.
Hammadeh MY, Madaan S, Hines J, Philp T (2003) 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection. Urology 61: 1166–1171CrossRefPubMed
28.
Hargreave TB, Heynes CF, Kendrick SW et al. (1996) Mortality after transurethral and open prostatectomy in Scotland. Br J Urol 77: 547–553PubMed
29.
Hill B, Belville W, Bruskewitz R et al. (2004) Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 171: 2336–2340CrossRefPubMed
30.
Hoffman RM, MacDonald R, Monga M, Wilt TJ (2004) Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 94: 1031–1036CrossRefPubMed
31.
Hofstetter A (1991) Interstitielle Thermokoagulation (ITK) von Prostatatumoren. Lasermedizin 7: 179–180
32.
Holman CD, Wisniewski ZS, Semmens JB et al. (1999) Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia. BJU Int 84: 37–42CrossRefPubMed
33.
Holmes M, Cox J, Stewart J et al. (2002) Thick vs thin loop transurethral resection of the prostate: a double-blind prospective trial of early morbidity. BJU Int 89: 197–201CrossRefPubMed
34.
Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87: 450–459PubMed
35.
Horninger W, Unterlechner H, Strasser H, Bartsch G (1996) Transurethral prostatectomy: mortality and morbidity. Prostate 28: 195–200CrossRefPubMed
36.
Kaplan SA, Te AE (1995) Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 45: 566–572CrossRefPubMed
37.
Knoll T, Michel MS, Trojan L et al. (2003) Long-term follow-up of interstitial laser coagulation in the treatment of benign prostatic hyperplasia. Aktuelle Urol 34: 48–51CrossRefPubMed
38.
Koshiba K, Egawa S, Ohori M et al. (1995) Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol 153: 1506–1509CrossRefPubMed
39.
Laguna MP, Alivizatos G, De La Rosette JJ (2003) Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol 17: 595–600CrossRefPubMed
40.
Liedberg F, Adell L, Hagberg G, Palmqvist IB (2003) Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement – a prospective randomized study. Scand J Urol Nephrol 37: 494–497CrossRefPubMed
41.
Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83: 227–237CrossRefPubMed
42.
Madersbacher S, Alivizatos G, Nordling J et al. (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46: 547–554CrossRefPubMed
43.
Madersbacher S, Lackner J, Brossner C et al. (2005) Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47: 499–504CrossRefPubMed
44.
Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174: 1344–1348CrossRefPubMed
45.
Mariano MB, Tefilli MV, Graziottin TM et al. (2006) Laparoscopic prostatectomy for benign prostatic hyperplasia – a six-year experience. Eur Urol 49: 127–131CrossRefPubMed
46.
Matlaga BR, Kim SC, Kuo RL et al. (2006) Holmium laser enucleation of the prostate for prostates of >125 mL. BJU Int 97: 81–84CrossRefPubMed
47.
Mearini E, Marzi M, Mearini L et al. (1998) Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. Eur Urol 34: 480–485CrossRefPubMed
48.
Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141: 243–247PubMed
49.
Millin T (1947) Retropubic urinary surgery. E&S Livingstone, Edinburgh
50.
Montorsi F, Naspro R, Salonia A et al. (2004) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172: 1926–1929CrossRefPubMed
51.
Moody JA, Lingeman JE (2001) Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy. J Urol 165: 459–462CrossRefPubMed
52.
Muschter R, Hofstetter A (1995) Technique and results of interstitial laser coagulation. World J Urol 13: 109–114CrossRefPubMed
53.
Muschter R, Hessel S, Hofstetter A et al. (1993) Interstitial laser coagulation of benign prostatic hyperplasia. Urologe A 32: 273–281PubMed
54.
Naslund MJ, Carlson AM, Williams MJ (2005) A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period. J Urol 173: 2090–2093CrossRefPubMed
55.
Naspro R, Salonia A, Colombo R et al. (2005) Update of the minimally invasive therapies for benign prostatic hyperplasia. Curr Opin Urol 15: 49–53CrossRefPubMed
56.
Rehman J, Khan SA, Sukkarieh T et al. (2005) Extraperitoneal laparoscopic prostatectomy (adenomectomy) for obstructing benign prostatic hyperplasia: transvesical and transcapsular (Millin) techniques. J Endourol 19: 491–496CrossRefPubMed
57.
Reich O, Corvin S, Oberneder R et al. (2002) In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP). Urol Res 30: 15–20CrossRefPubMed
58.
Reich O, Bachmann A, Siebels M et al. (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173: 158–160PubMed
59.
Roos NP, Wennberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320: 1120–1124PubMed
60.
Sandhu JS, Ng C, Vanderbrink BA et al. (2004) High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64: 1155–1159CrossRefPubMed
61.
Sarica K, Alkan E, Luleci H, Tasci AI (2005) Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 19: 1199–1202CrossRefPubMed
62.
Schatzl G, Madersbacher S, Djavan B et al. (2000) Two-year results of transurethral resection of the prostate versus four ‚less invasive‘ treatment options. Eur Urol 37: 695–701CrossRefPubMed
63.
64.
Shalev M, Richter S, Kessler O et al. (1999) Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia. J Urol 161: 491–493CrossRefPubMed
65.
Sotelo R, Spaliviero M, Garcia-Segui A et al. (2005) Laparoscopic retropubic simple prostatectomy. J Urol 173: 757–760CrossRefPubMed
66.
Starkman JS, Santucci RA (2005) Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int 95: 69–71CrossRefPubMed
67.
Talic RF, El Tiraifi A, El Faqih SR et al. (2000) Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology 55: 886–890CrossRefPubMed
68.
Tan AH, Gilling PJ (2005) Lasers in the treatment of benign prostatic hyperplasia: an update. Curr Opin Urol 15: 55–58CrossRefPubMed
69.
Tan AH, Gilling PJ, Kennett KM et al. (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170: 1270–1274CrossRefPubMed
70.
Te AE, Malloy TR, Stein BS et al. (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172: 1404–1408CrossRefPubMed
71.
Tefekli A, Muslumanoglu AY, Baykal M et al. (2005) A hybrid technique using bipolar energy in transurethral prostate surgery: a prospective, randomized comparison. J Urol 174: 1339–1343CrossRefPubMed
72.
Terada N, Arai Y, Okubo K et al. (2004) Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up. Int J Urol 11: 978–982CrossRefPubMed
73.
Thomas AW, Cannon A, Bartlett E et al. (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow up of transurethral resection of prostate for bladder outlet obstruction. J Urol 174: 1887–1891CrossRefPubMed
74.
Tkocz M, Prajsner A (2002) Comparison of long-term results of transurethral incision of the prostate with transurethral resection of the prostate, in patients with benign prostatic hypertrophy. Neurourol Urodyn 21: 112–116CrossRefPubMed
75.
Tooher R, Sutherland P, Costello A et al. (2004) A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 171: 1773–1781CrossRefPubMed
76.
Van Melick HH, Van Venrooij GE, Boon TA (2003) Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization. Urology 62: 1029–1034CrossRefPubMed
77.
Varkarakis J, Bartsch G, Horninger W (2004) Long-term morbidity and mortality of transurethral prostatectomy: a 10-year follow-up. Prostate 58: 248–251CrossRefPubMed
78.
Varkarakis I, Kyriakakis Z, Delis A et al. (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 64: 306–310CrossRefPubMed
79.
Vesely S, Knutson T, Dicuio M et al. (2005) Transurethral microwave thermotherapy: clinical results after 11 years of use. J Endourol 19: 730–733CrossRefPubMed
80.
Volkan T, Ihsan TA, Yilmaz O et al. (2005) Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 48: 608–613CrossRefPubMed
81.
Walmsley K, Kaplan SA (2004) Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol 172: 1249–1255CrossRefPubMed
82.
Wasson JH, Bubolz TA, Lu-Yao GL et al. (2000) Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol 164: 1212–1215CrossRefPubMed
83.
Wendt-Nordahl G, Hacker A, Reich O et al. (2004) The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol 46: 586–590CrossRefPubMed
84.
Yang Q, Peters TJ, Donovan JL et al. (2001) Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol 165: 1526–1532CrossRefPubMed
85.
Zlotta AR, Giannakopoulos X, Maehlum O et al. (2003) Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers. Eur Urol 44: 89–93CrossRefPubMed
86.
Zwergel U, Wullich B, Lindenmeir U et al. (1998) Long-term results following transurethral resection of the prostate. Eur Urol 33: 476–480CrossRefPubMed
Metadaten
Titel
Benignes Prostatasyndrom (BPS)
Ablative Verfahren
verfasst von
PD Dr. O. Reich
M. Seitz
C. Gratzke
B. Schlenker
A. Bachmann
C. Stief
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
Die Urologie / Ausgabe 6/2006
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-006-1039-1

Weitere Artikel der Ausgabe 6/2006

Der Urologe 6/2006 Zur Ausgabe

Leitthema

High-dose-rate-Brachytherapie beim Risikoprostatakarzinom

Einführung zum Thema

Strahlentherapie und moderne Bildgebung

Berufspolitik Österr.Berufsverband

Mitteilungen Österr. Berufsverband

AUO

Über Erfolg und Misserfolg interdisziplinärer Studien

Leitthema

Weiterentwicklung der PET und des PET/CT beim Prostatakarzinom

Originalien

Sentinel-Lymphadenektomie beim Prostatakarzinom

Neu im Fachgebiet Urologie

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise